Get startedLog in
    Picture of Shield Therapeutics logo

    STX — Shield Therapeutics News Story

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Shield Therapeutics Says All Primary Endpoints Met In Phase 3 Paediatric Study

    Picture of Shield Therapeutics logoShield Therapeutics
    25/09/2024 07:40
    Sept 25 (Reuters) - Shield Therapeutics PLC  STXS.L :
    * SHIELD THERAPEUTICS  - RESULTS FROM PHASE 3 PAEDIATRIC
STUDY
    * SHIELD THERAPEUTICS PLC: ALL PRIMARY ENDPOINTS MET IN
PHASE 3
PAEDIATRIC STUDY

Source text for Eikon:  ID:nRSY4852Fa 
Further company coverage:  STXS.L 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shield Therapeutics

    See all news